Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Farmers Insurance
Cipla
Healthtrust
Medtronic
Fish and Richardson
Daiichi Sankyo
UBS
Johnson and Johnson
Colorcon

Generated: October 23, 2017

DrugPatentWatch Database Preview

IMURAN Drug Profile

« Back to Dashboard

What is the patent landscape for Imuran, and when can generic versions of Imuran launch?

Imuran is a drug marketed by Sebela Ireland Ltd and Casper Pharma Llc and is included in two NDAs.

The generic ingredient in IMURAN is azathioprine sodium. There are fourteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the azathioprine sodium profile page.

Summary for Tradename: IMURAN

US Patents:0
Applicants:2
NDAs:2
Suppliers / Packagers: see list1
Bulk Api Vendors: see list74
Clinical Trials: see list17
Patent Applications: see list9,235
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:IMURAN at DailyMed

Pharmacology for Tradename: IMURAN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sebela Ireland Ltd
IMURAN
azathioprine
TABLET;ORAL016324-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Sebela Ireland Ltd
IMURAN
azathioprine
TABLET;ORAL016324-001Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe► Subscribe
Casper Pharma Llc
IMURAN
azathioprine sodium
INJECTABLE;INJECTION017391-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Colorcon
Moodys
Argus Health
Federal Trade Commission
Covington
QuintilesIMS
UBS
Cantor Fitzgerald
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot